Sunzen Biotech Bhd (0148) — Capital Reinvestment Ratio
Latest as of September 2023:
0.03x
Sunzen Biotech Bhd (0148) has a Capital Reinvestment Ratio of 0.03x as of September 2023, meaning it reinvests 0% of its operating cash flow (RM3.58 Million) in capital expenditures (RM95.00K). See Sunzen Biotech Bhd (0148) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.03x
Capex / Operating Cash Flow
Operating Cash Flow
RM3.58 Million
MYR
Capital Expenditures
RM95.00K
MYR
Data as of
Sep 2023
Most recent filing
Sunzen Biotech Bhd Capital Reinvestment Ratio (2016–2023)
This chart tracks Sunzen Biotech Bhd's Capital Reinvestment Ratio across 4 annual periods.
Annual Capital Reinvestment Ratio for Sunzen Biotech Bhd (2016–2023)
Year-by-year Capital Reinvestment Ratio for Sunzen Biotech Bhd from 2016 to 2023. For live market cap and broader valuation context, see Sunzen Biotech Bhd market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (MYR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 1.23x | RM819.39K | RM1.01 Million | ▲ +667.0% |
| 2020 | 0.16x | RM7.20 Million | RM1.16 Million | ▼ -81.1% |
| 2017 | 0.85x | RM4.02 Million | RM3.42 Million | ▼ -96.7% |
| 2016 | 25.91x | RM256.13K | RM6.64 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow